Viola Ghizzoni

Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

Sabrina Chiara Cecere, Gaia Giannone, Vanda Salutari et al. · Gynecologic Oncology · 2019 · 103 citations · Full text

Medicine, Cancer Management, Gynecology +9

New adverse obstetrics outcomes associated with endometriosis: a retrospective cohort study

Luca Mannini, Flavia Sorbi, Ivo Noci et al. · Archives of Gynecology and Obstetrics · 2016 · 46 citations

Retrospective Cohort Study, Maternal Complication, Reproductive Health +8

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial

Sandro Pignata, Giovanni Scambia, Clorinda Schettino et al. · The Lancet Oncology · 2023 · 46 citations

Medicine, Cancer Management, Mito End-3 +7

One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer

Francesco Fanfani, Giorgia Monterossi, Viola Ghizzoni et al. · PLoS ONE · 2018 · 43 citations · Full text

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22)

Lucia Musacchio, Daniela Califano, Michele Bartoletti et al. · British Journal of Cancer · 2022 · 25 citations · Full text

Tumoral Pathology, Medicine, Mito 22 +8